• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用呼出的挥发性有机化合物进行哮喘的无创表型分析。

Non-invasive phenotyping using exhaled volatile organic compounds in asthma.

机构信息

Respiratory Research Group, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

出版信息

Thorax. 2011 Sep;66(9):804-9. doi: 10.1136/thx.2010.156695. Epub 2011 Jul 11.

DOI:10.1136/thx.2010.156695
PMID:21749985
Abstract

BACKGROUND

Breath volatile organic compounds (VOCs) may be useful for asthma diagnosis and phenotyping, identifying patients who could benefit from personalised therapeutic strategies. The authors aimed to identify specific patterns of breath VOCs in patients with asthma and in clinically relevant disease phenotypes.

METHODS

Breath samples were analysed by gas chromatography-mass spectrometry. The Asthma Control Questionnaire was completed, together with lung function and induced sputum cell counts. Breath data were reduced to principal components, and these principal components were used in multiple logistic regression to identify discriminatory models for diagnosis, sputum inflammatory cell profile and asthma control.

RESULTS

The authors recruited 35 patients with asthma and 23 matched controls. A model derived from 15 VOCs classified patients with asthma with an accuracy of 86%, and positive and negative predictive values of 0.85 and 0.89, respectively. Models also classified patients with asthma based on the following phenotypes: sputum (obtained in 18 patients with asthma) eosinophilia ≥2% area under the receiver operating characteristics (AUROC) curve 0.98, neutrophilia ≥40% AUROC 0.90 and uncontrolled asthma (Asthma Control Questionnaire ≥1) AUROC 0.96.

CONCLUSIONS

Detection of characteristic breath VOC profiles could classify patients with asthma versus controls, and clinically relevant disease phenotypes based on sputum inflammatory profile and asthma control. Prospective validation of these models may lead to clinical application of non-invasive breath profiling in asthma.

摘要

背景

呼吸挥发性有机化合物(VOCs)可能有助于哮喘的诊断和表型分析,以确定可能从个体化治疗策略中获益的患者。作者旨在确定哮喘患者和临床相关疾病表型中呼吸 VOCs 的特定模式。

方法

使用气相色谱-质谱法分析呼吸样本。完成哮喘控制问卷,同时进行肺功能和诱导痰细胞计数。将呼吸数据简化为主成分,然后将这些主成分用于多元逻辑回归,以确定用于诊断、痰炎症细胞谱和哮喘控制的判别模型。

结果

作者招募了 35 名哮喘患者和 23 名匹配的对照者。由 15 种 VOC 组成的模型将哮喘患者分类的准确率为 86%,阳性和阴性预测值分别为 0.85 和 0.89。该模型还根据以下表型对哮喘患者进行分类:痰(18 名哮喘患者中获得)嗜酸性粒细胞≥2% 受试者工作特征(ROC)曲线下面积(AUROC)为 0.98,中性粒细胞≥40% AUROC 为 0.90,未控制的哮喘(哮喘控制问卷≥1)AUROC 为 0.96。

结论

检测特征性呼吸 VOC 谱可将哮喘患者与对照者以及基于痰炎症谱和哮喘控制的临床相关疾病表型进行分类。对这些模型进行前瞻性验证可能会导致非侵入性呼吸分析在哮喘中的临床应用。

相似文献

1
Non-invasive phenotyping using exhaled volatile organic compounds in asthma.使用呼出的挥发性有机化合物进行哮喘的无创表型分析。
Thorax. 2011 Sep;66(9):804-9. doi: 10.1136/thx.2010.156695. Epub 2011 Jul 11.
2
Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.呼出气成分分析有助于鉴别慢性阻塞性肺疾病和哮喘。
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1076-82. doi: 10.1164/rccm.200906-0939OC. Epub 2009 Aug 27.
3
Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.哮喘儿童的呼吸道症状和呼气峰值流速与呼出气及环境空气中挥发性有机化合物的关系。
J Expo Anal Environ Epidemiol. 2003 Sep;13(5):348-63. doi: 10.1038/sj.jea.7500287.
4
A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.一项关于体外培养的肺癌细胞呼出的挥发性有机化合物用于呼气诊断的研究。
Cancer. 2007 Aug 15;110(4):835-44. doi: 10.1002/cncr.22844.
5
External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.采用电子鼻技术对呼出气进行分析用于鉴别固定气道阻塞性疾病(如哮喘)与慢性阻塞性肺疾病的外部验证。
Clin Exp Allergy. 2011 Oct;41(10):1371-8. doi: 10.1111/j.1365-2222.2011.03800.x. Epub 2011 Jul 7.
6
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.非小细胞肺癌患者呼出的挥发性有机化合物:横断面和嵌套短期随访研究
Respir Res. 2005 Jul 14;6(1):71. doi: 10.1186/1465-9921-6-71.
7
A profile of volatile organic compounds in breath discriminates COPD patients from controls.呼出气中挥发性有机化合物谱鉴别慢性阻塞性肺疾病患者与对照。
Respir Med. 2010 Apr;104(4):557-63. doi: 10.1016/j.rmed.2009.10.018. Epub 2009 Nov 10.
8
An electronic nose in the discrimination of patients with asthma and controls.电子鼻在鉴别哮喘患者与对照者中的应用
J Allergy Clin Immunol. 2007 Oct;120(4):856-62. doi: 10.1016/j.jaci.2007.05.043. Epub 2007 Jul 20.
9
Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air.基于人体呼出气体中挥发性有机化合物分析的精确分类方法的开发。
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 1;861(1):101-7. doi: 10.1016/j.jchromb.2007.11.008. Epub 2007 Nov 19.
10
Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.通过临床特征和呼出气体中挥发性有机化合物的模式来定义成人哮喘的内型。
Respir Res. 2014 Nov 28;15(1):136. doi: 10.1186/s12931-014-0136-8.

引用本文的文献

1
Adhesion molecules in focus: mechanistic pathways and therapeutic avenues in sickle cell vaso-occlusion - a narrative review.聚焦黏附分子:镰状细胞血管闭塞的机制途径与治疗方法——一篇叙述性综述
Ann Med Surg (Lond). 2025 Jul 18;87(9):5775-5783. doi: 10.1097/MS9.0000000000003619. eCollection 2025 Sep.
2
Development of a new breath collection method for analyzing volatile organic compounds from intubated mouse models.一种用于分析来自插管小鼠模型的挥发性有机化合物的新型呼气收集方法的开发。
Biol Methods Protoc. 2024 Nov 14;9(1):bpae087. doi: 10.1093/biomethods/bpae087. eCollection 2024.
3
Partial role of volatile organic compounds in behavioural responses of mice to bedding from cancer-affected congeners.
挥发性有机化合物在患癌同窝仔鼠对垫料的行为反应中的部分作用。
Biol Open. 2024 Jul 15;13(10). doi: 10.1242/bio.060324. Epub 2024 Oct 1.
4
Evidence for widespread human exposure to food contact chemicals.有证据表明人类广泛接触食品接触化学品。
J Expo Sci Environ Epidemiol. 2025 May;35(3):330-341. doi: 10.1038/s41370-024-00718-2. Epub 2024 Sep 17.
5
Exhaled volatile organic compounds (VOCs) for prediction of asthma exacerbation in children.呼气挥发性有机化合物 (VOCs) 预测儿童哮喘恶化。
Int J Occup Med Environ Health. 2024 Sep 10;37(3):351-359. doi: 10.13075/ijomeh.1896.02442. Epub 2024 Sep 4.
6
Exhaled Volatile Organic Compounds Detection in Pneumonia Screening: A Comprehensive Meta-analysis.呼气挥发性有机化合物检测在肺炎筛查中的应用:一项综合荟萃分析。
Lung. 2024 Oct;202(5):501-511. doi: 10.1007/s00408-024-00737-8. Epub 2024 Aug 24.
7
Fulfilling the Promise of Breathomics: Considerations for the Discovery and Validation of Exhaled Volatile Biomarkers.实现呼吸组学的承诺:呼气挥发性生物标志物的发现和验证的考虑因素。
Am J Respir Crit Care Med. 2024 Nov 1;210(9):1079-1090. doi: 10.1164/rccm.202305-0868TR.
8
Discovery and Validation of a Volatile Signature of Eosinophilic Airway Inflammation in Asthma.哮喘嗜酸性气道炎症挥发性特征的发现和验证。
Am J Respir Crit Care Med. 2024 Nov 1;210(9):1101-1112. doi: 10.1164/rccm.202310-1759OC.
9
Enhanced real-time mass spectrometry breath analysis for the diagnosis of COVID-19.用于COVID-19诊断的增强型实时质谱呼吸分析
ERJ Open Res. 2023 Sep 18;9(5). doi: 10.1183/23120541.00206-2023. eCollection 2023 Sep.
10
Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review.呼出的挥发性有机化合物与阻塞性肺疾病风险因素的关联:一项系统综述
ERJ Open Res. 2023 Aug 29;9(4). doi: 10.1183/23120541.00143-2023. eCollection 2023 Jul.